Keep an eye on monkeypox stocks, like Chimerix (CMRX).
“Epidemiologists, public health officials and doctors now fear the government cannot eliminate the disease in that community, and they’re warning that they are running out of time to stop the virus from spreading in the U.S. population more broadly,” says Politico.
Worse, companies such as Bavarian Nordic just warned it may not be able to supply enough vaccines to satisfy demand. As noted by Barron’s: Rolf Sass Sorensen, a spokesperson for the company, was quoted by Bloomberg saying: “Demand keeps rising and it’s no longer certain that we can continue to meet the demand we’re facing even with the upgrade of our existing manufacturing site in Denmark.”
That being said, CMRX could run higher, as demand rises.